Cumulus Neuroscience Appoints Ricardo Sáinz Fuertes, MD as New Board Chair
Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, announced today that Ricardo Sáinz Fuertes, MD, MSc, PhD, FRCPsych, EDTX has been appointed Chair of the Company’s…
Withings Redefines Preventive Health with Body Scan 2
Withings Redefines Preventive Health with Body Scan 2
After inventing the world’s first connected scale in 2009, Withings is redefining preventive health once again with Body Scan 2, the...
Circular Genomics Adds Leading Alzheimer’s Experts to SAB
Circular Genomics Adds Leading Alzheimer’s Experts to SAB
Michael Weiner, MD and Timothy Hohman, PhD, bring decades of experience in neurological diseases with a focus on Alzheimer’s disease...
Circular Genomics Announces Closure of $15 Million Series A Financing
Circular Genomics Announces Closure of $15 Million Series A Financing
Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with...
Quanterix Announces Board and Leadership Changes for Next Growth Phase
Quanterix Announces Board and Leadership Changes for Next Growth Phase
Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey...